These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

434 related articles for article (PubMed ID: 12419832)

  • 61. Association between glutathione S-transferase T1, M1, and P1 genotypes and the risk of colorectal cancer.
    Cong N; Liu L; Xie Y; Shao W; Song J
    J Korean Med Sci; 2014 Nov; 29(11):1488-92. PubMed ID: 25408579
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Polymorphisms of cytochrome P4501A2 and N-acetyltransferase genes, smoking, and risk of pancreatic cancer.
    Li D; Jiao L; Li Y; Doll MA; Hein DW; Bondy ML; Evans DB; Wolff RA; Lenzi R; Pisters PW; Abbruzzese JL; Hassan MM
    Carcinogenesis; 2006 Jan; 27(1):103-11. PubMed ID: 15987714
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Role of NQO1C609T and EPHX1 gene polymorphisms in the association of smoking and alcohol with sporadic distal colorectal adenomas: results from the UKFSS Study.
    Mitrou PN; Watson MA; Loktionov AS; Cardwell C; Gunter MJ; Atkin WS; Macklin CP; Cecil T; Bishop DT; Primrose J; Bingham SA
    Carcinogenesis; 2007 Apr; 28(4):875-82. PubMed ID: 17082176
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Genetic polymorphism of CYP2D6, GSTM1 and NAT2 and susceptibility to haematological neoplasias.
    Lemos MC; Cabrita FJ; Silva HA; Vivan M; Plácido F; Regateiro FJ
    Carcinogenesis; 1999 Jul; 20(7):1225-9. PubMed ID: 10383893
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Cigarette smoking, genetic polymorphisms and colorectal cancer risk: the Fukuoka Colorectal Cancer Study.
    Nisa H; Kono S; Yin G; Toyomura K; Nagano J; Mibu R; Tanaka M; Kakeji Y; Maehara Y; Okamura T; Ikejiri K; Futami K; Maekawa T; Yasunami Y; Takenaka K; Ichimiya H; Terasaka R
    BMC Cancer; 2010 Jun; 10():274. PubMed ID: 20534171
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Metabolic activation of polycyclic aromatic hydrocarbons and other procarcinogens by cytochromes P450 1A1 and P450 1B1 allelic variants and other human cytochromes P450 in Salmonella typhimurium NM2009.
    Shimada T; Oda Y; Gillam EM; Guengerich FP; Inoue K
    Drug Metab Dispos; 2001 Sep; 29(9):1176-82. PubMed ID: 11502724
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Interaction of the cytochrome P4501A2, SULT1A1 and NAT gene polymorphisms with smoking and dietary mutagen intake in modification of the risk of pancreatic cancer.
    Suzuki H; Morris JS; Li Y; Doll MA; Hein DW; Liu J; Jiao L; Hassan MM; Day RS; Bondy ML; Abbruzzese JL; Li D
    Carcinogenesis; 2008 Jun; 29(6):1184-91. PubMed ID: 18499698
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Bladder cancer risk and genetic variation in AKR1C3 and other metabolizing genes.
    Figueroa JD; Malats N; García-Closas M; Real FX; Silverman D; Kogevinas M; Chanock S; Welch R; Dosemeci M; Lan Q; Tardón A; Serra C; Carrato A; García-Closas R; Castaño-Vinyals G; Rothman N
    Carcinogenesis; 2008 Oct; 29(10):1955-62. PubMed ID: 18632753
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Genetic polymorphisms of biotransformation enzymes in patients with Hodgkin's and non-Hodgkin's lymphomas.
    Soucek P; Sarmanová J; Kristensen VN; Apltauerová M; Gut I
    Int Arch Occup Environ Health; 2002 Oct; 75 Suppl():S86-92. PubMed ID: 12397416
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Red meat intake, doneness, polymorphisms in genes that encode carcinogen-metabolizing enzymes, and colorectal cancer risk.
    Cotterchio M; Boucher BA; Manno M; Gallinger S; Okey AB; Harper PA
    Cancer Epidemiol Biomarkers Prev; 2008 Nov; 17(11):3098-107. PubMed ID: 18990750
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Association of NAT2, GSTM1, GSTT1, CYP2A6, and CYP2A13 gene polymorphisms with susceptibility and clinicopathologic characteristics of bladder cancer in Central China.
    Song DK; Xing DL; Zhang LR; Li ZX; Liu J; Qiao BP
    Cancer Detect Prev; 2009; 32(5-6):416-23. PubMed ID: 19303722
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Dietary glucosinolate intake, polymorphisms in selected biotransformation enzymes, and risk of prostate cancer.
    Steinbrecher A; Rohrmann S; Timofeeva M; Risch A; Jansen E; Linseisen J
    Cancer Epidemiol Biomarkers Prev; 2010 Jan; 19(1):135-43. PubMed ID: 20056632
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Polymorphism of selected enzymes involved in detoxification and biotransformation in relation to lung cancer.
    Gresner P; Gromadzinska J; Wasowicz W
    Lung Cancer; 2007 Jul; 57(1):1-25. PubMed ID: 17337085
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Analysis of the polymorphic alleles of genes encoding phase 1 and phase 2 detoxication enzymes in patients with endometriosis].
    Ivashchenko TE; Shved NIu; Kramareva NA; Aĭlamazian EK; Baranov VS
    Genetika; 2003 Apr; 39(4):525-9. PubMed ID: 12760253
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Polymorphism of drug-metabolizing enzymes in relation to individual susceptibility to industrial chemicals.
    Nakajima T; Aoyama T
    Ind Health; 2000 Apr; 38(2):143-52. PubMed ID: 10812837
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Genetic polymorphisms of phase I and phase II metabolic enzymes as modulators of lung cancer susceptibility.
    Mota P; Silva HC; Soares MJ; Pego A; Loureiro M; Cordeiro CR; Regateiro FJ
    J Cancer Res Clin Oncol; 2015 May; 141(5):851-60. PubMed ID: 25388590
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Genetic susceptibility according to three metabolic pathways in cancers of the lung and bladder and in myeloid leukemias in nonsmokers.
    Vineis P; Veglia F; Garte S; Malaveille C; Matullo G; Dunning A; Peluso M; Airoldi L; Overvad K; Raaschou-Nielsen O; Clavel-Chapelon F; Linseisen JP; Kaaks R; Boeing H; Trichopoulou A; Palli D; Crosignani P; Tumino R; Panico S; Bueno-De-Mesquita HB; Peeters PH; Lund E; Gonzalez CA; Martinez C; Dorronsoro M; Barricarte A; Navarro C; Quiros JR; Berglund G; Jarvholm B; Day NE; Key TJ; Saracci R; Riboli E; Autrup H
    Ann Oncol; 2007 Jul; 18(7):1230-42. PubMed ID: 17496311
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Microsomal epoxide hydrolase and glutathione S-transferase polymorphisms in relation to laryngeal carcinoma risk.
    To-Figueras J; Gené M; Gómez-Catalán J; Piqué E; Borrego N; Caballero M; Cruellas F; Raya A; Dicenta M; Corbella J
    Cancer Lett; 2002 Dec; 187(1-2):95-101. PubMed ID: 12359356
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Aromatic DNA adducts and number of lung cancer risk alleles in Map-Ta-Phut Industrial Estate workers and nearby residents.
    Peluso M; Srivatanakul P; Jedpiyawongse A; Sangrajrang S; Munnia A; Piro S; Ceppi M; Boffetta P; Godschalk RW; van Schooten FJ
    Mutagenesis; 2013 Jan; 28(1):57-63. PubMed ID: 22987024
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Colorectal cancer and genetic polymorphisms of CYP1A1, GSTM1 and GSTT1: a case-control study in the Grampian region of Scotland.
    Little J; Sharp L; Masson LF; Brockton NT; Cotton SC; Haites NE; Cassidy J
    Int J Cancer; 2006 Nov; 119(9):2155-64. PubMed ID: 16823842
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.